A new aggressive form of HIV can progress to AIDS in just three years - so rapidly that patients may not even realise they were infected, scientists say. Engaging in unprotected sex with multiple partners increases the risk of contracting multiple strains of HIV. Once inside a host, these strains can recombine into a new variant of the virus, researchers said.
Emergent BioSolutions under several agreements signed with the Oxford university, GSK and the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) respectively, it has manufactured a modified vaccinia Ankara (MVA) Ebola Zaire vaccine candidate (MVA EBOZ) anticipated for use in a Phase 1 clinical study to be conducted by Professor Adrian Hill of the Jenner Institute.


